These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4977045)

  • 21. [Antibiotic sensitivity of gram-negative bacilli isolated from lesions since 1965].
    Yamaji Y; Takahashi M; Miyanaga Y; Todome Y; Motoyama M
    Jpn J Antibiot; 1968 Feb; 21(1):25-33. PubMed ID: 4174373
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of phosphonomycin, a new cell wall-active antibiotic.
    Clark H; Brown NK; Wallace JF; Turck M
    Antimicrob Agents Chemother (Bethesda); 1969; 9():338-42. PubMed ID: 4990371
    [No Abstract]   [Full Text] [Related]  

  • 23. Nalidixic acid plus sodium citrate twice daily in the treatment of acute urinary tract infection. Swedish Collaborative Study Group.
    Scand J Prim Health Care; 1988 Feb; 6(1):59-63. PubMed ID: 3281205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of nevigramon in acute and chronic pyelonephritis before and after kidney transplantation].
    Iarmolinskiĭ IS; Vasina TA; Ploshkina NS; Goriaĭnov VA
    Antibiotiki; 1971 Feb; 16(2):177-9. PubMed ID: 4997523
    [No Abstract]   [Full Text] [Related]  

  • 25. Gentamicin: Antibacterial activity in vitro and clinical studies.
    Altucci P; Sapio U; Esposito E
    Chemotherapy; 1965-1966; 10(5):312-20. PubMed ID: 4958548
    [No Abstract]   [Full Text] [Related]  

  • 26. The interaction patterns of combined antibacterial agents. Experiments with two agardiffusion methods.
    Mouton RP; Koelman A
    Chemotherapy; 1966; 11(1):10-26. PubMed ID: 4959585
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nalidixic acid in chronic urinary tract infections].
    Gasser G; Neuhold R
    Wien Med Wochenschr; 1967 Mar; 117(8):192-6. PubMed ID: 5589339
    [No Abstract]   [Full Text] [Related]  

  • 28. Bacteriuria and chronic renal disease.
    Schlegel JU; Goff JB; O'Dell RM
    Trans Am Assoc Genitourin Surg; 1967; 59():32-6. PubMed ID: 6064527
    [No Abstract]   [Full Text] [Related]  

  • 29. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
    Guimaraes MA; Noone P
    J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiences on the efficacy and safety of nalidixic acid, oxolinic acid, cinoxacin and norfloxacin in the treatment of urinary tract infections (UTI).
    Sabbour MS; El Bokl MA; Osman LM
    Infection; 1984; 12(6):377-80. PubMed ID: 6240470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transferable drug resistance among Enterobacteriaceae isolated from human urinary tract infections.
    Sieckmann DG; Reed ND; Georgi CE
    Appl Microbiol; 1969 May; 17(5):701-6. PubMed ID: 4891720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparison of cinoxacin and nalidixic acid in the treatment of chronic urinary tract infections].
    Briedigkeit H; Schimmelpfennig R; Buder R; Precht K; Dröseler H
    Infection; 1982; 10(4):219-22. PubMed ID: 7129643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of Minocycline and Ampicillin in the treatment of urinary tract infections.
    Klastersky J; Daneau D
    Int J Clin Pharmacol; 1974 Mar; 9(2):125-31. PubMed ID: 4208030
    [No Abstract]   [Full Text] [Related]  

  • 35. Emergence of resistant organisms as a function of dose in oxolinic acid therapy.
    Clark H; Brown NK; Wallace JF; Turck M
    Am J Med Sci; 1971 Mar; 261(3):145-8. PubMed ID: 4933875
    [No Abstract]   [Full Text] [Related]  

  • 36. Nalidixic acid.
    Bailey RR
    JAMA; 1977 Jun; 237(25):2720. PubMed ID: 577224
    [No Abstract]   [Full Text] [Related]  

  • 37. The new quinolones and their combinations with other agents for therapy of severe infections.
    Desplaces N; Gutmann L; Carlet J; Guibert J; Acar JF
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():25-39. PubMed ID: 3011726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oxolinic acid therapy of urinary tract infections in infancy].
    Marosvári I; Schmidt M
    Acta Paediatr Acad Sci Hung; 1976; 17(4):317-22. PubMed ID: 801102
    [No Abstract]   [Full Text] [Related]  

  • 39. [Susceptibility of various bacteria isolated from patients with infections of the urinary tract against carbenicillin].
    Ringelmann R; Goeschel U; Höffler D
    Immun Infekt; 1973 Oct; 1(1):43-50. PubMed ID: 4219780
    [No Abstract]   [Full Text] [Related]  

  • 40. [Microbial spectrum and microbial resistance in ambulatory and stationary urological patients].
    Weissbach L; Tümmers H; Primavesi CA
    Z Urol Nephrol; 1970 Oct; 63(10):763-71. PubMed ID: 4994620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.